No further spread of polio virus after contamination employee The employee of a Dutch vaccine manufacturer, who was infected with the polio virus in early April, is no longer carrying the virus.
HPV vaccination not only protects against cervical cancer HPV vaccination against cervical cancer also appears to protect against other forms of cancer that can be caused by HPV.
Blood analysis local residents confirms longtime exposure to PFOA The results of blood analysis show that measured blood values correspond well with the calculated values in an earlier study in 2016 on the emission of perfluorooctanoic acid (PFOA) by DuPont/Chemo
More knowledge required about environmental effect of GenX More knowledge is required about the extent to which GenX substances accumulate in fish.
Meningococcal immunisation recommendations re-examined Meningococcal disease is a very serious infectious disease that can cause meningitis or blood poisoning. Children are immunised against meningococcal serogroup C at 14 months.
Employee vaccine manufacturer infected with polio virus Early April, a sealed room at a vaccine manufacturer was the site of an incident. Two employees were exposed to the polio virus.
Benefits and bottlenecks for early marketing authorisation of new medicines Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.
Particle contamination on Silimed breast implants poses minimal risk Particles were found on Silimed silicone-based breast implants that should not be there. These included man-made mineral fibres, such as glasswool and rockwool.
European Baseline Report SUSTAIN The SUSTAIN project has published the European baseline report titled ‘Integrated care for older people living at home – Current situation and ambition of sites participating in the SUSTAIN project
EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.